adc-20220630June 30, 2022000177191012月31日假象2022Q200017719102022-01-012022-06-300001771910ADC：ProductRevenueNetMember2022-04-012022-06-30ISO 4217：美元0001771910ADC：ProductRevenueNetMember2021-04-012021-06-300001771910ADC：ProductRevenueNetMember2022-01-012022-06-300001771910ADC：ProductRevenueNetMember2021-01-012021-06-300001771910ADC：許可收入成員2022-04-012022-06-300001771910ADC：許可收入成員2021-04-012021-06-300001771910ADC：許可收入成員2022-01-012022-06-300001771910ADC：許可收入成員2021-01-012021-06-3000017719102022-04-012022-06-3000017719102021-04-012021-06-3000017719102021-01-012021-06-300001771910IFRS-Full：RetainedEarningsMembers2021-04-012021-06-30ISO 4217：美元Xbrli：共享00017719102022-06-3000017719102021-12-310001771910IFRS-Full：IssuedCapitalMembers2022-03-310001771910IFRS-Full：SharePremiumMembers2022-03-310001771910IFRS-FULL：其他保留成員2022-03-310001771910IFRS-Full：財務份額成員2022-03-310001771910Ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember2022-03-310001771910IFRS-Full：RetainedEarningsMembers2022-03-3100017719102022-03-310001771910IFRS-Full：RetainedEarningsMembers2022-04-012022-06-300001771910IFRS-FULL：其他保留成員2022-04-012022-06-300001771910Ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember2022-04-012022-06-300001771910IFRS-Full：SharePremiumMembers2022-04-012022-06-300001771910IFRS-Full：財務份額成員2022-04-012022-06-300001771910IFRS-Full：IssuedCapitalMembers2022-06-300001771910IFRS-Full：SharePremiumMembers2022-06-300001771910IFRS-FULL：其他保留成員2022-06-300001771910IFRS-Full：財務份額成員2022-06-300001771910Ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember2022-06-300001771910IFRS-Full：RetainedEarningsMembers2022-06-300001771910IFRS-Full：IssuedCapitalMembers2021-12-310001771910IFRS-Full：SharePremiumMembers2021-12-310001771910IFRS-FULL：其他保留成員2021-12-310001771910IFRS-Full：財務份額成員2021-12-310001771910Ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember2021-12-310001771910IFRS-Full：RetainedEarningsMembers2021-12-310001771910IFRS-Full：RetainedEarningsMembers2022-01-012022-06-300001771910IFRS-FULL：其他保留成員2022-01-012022-06-300001771910Ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember2022-01-012022-06-300001771910IFRS-Full：SharePremiumMembers2022-01-012022-06-300001771910IFRS-Full：財務份額成員2022-01-012022-06-300001771910IFRS-Full：IssuedCapitalMembers2022-01-012022-06-300001771910IFRS-Full：IssuedCapitalMembers2021-03-310001771910IFRS-Full：SharePremiumMembers2021-03-310001771910IFRS-FULL：其他保留成員2021-03-310001771910IFRS-Full：財務份額成員2021-03-310001771910Ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember2021-03-310001771910IFRS-Full：RetainedEarningsMembers2021-03-3100017719102021-03-310001771910Ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember2021-04-012021-06-300001771910IFRS-Full：IssuedCapitalMembers2021-04-012021-06-300001771910IFRS-Full：財務份額成員2021-04-012021-06-300001771910IFRS-Full：SharePremiumMembers2021-04-012021-06-300001771910IFRS-FULL：其他保留成員2021-04-012021-06-300001771910IFRS-Full：IssuedCapitalMembers2021-06-300001771910IFRS-Full：SharePremiumMembers2021-06-300001771910IFRS-FULL：其他保留成員2021-06-300001771910IFRS-Full：財務份額成員2021-06-300001771910Ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember2021-06-300001771910IFRS-Full：RetainedEarningsMembers2021-06-3000017719102021-06-300001771910IFRS-Full：IssuedCapitalMembers2020-12-310001771910IFRS-Full：SharePremiumMembers2020-12-310001771910IFRS-FULL：其他保留成員2020-12-310001771910IFRS-Full：財務份額成員2020-12-310001771910Ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember2020-12-310001771910IFRS-Full：RetainedEarningsMembers2020-12-3100017719102020-12-310001771910IFRS-Full：RetainedEarningsMembers2021-01-012021-06-300001771910Ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember2021-01-012021-06-300001771910IFRS-Full：IssuedCapitalMembers2021-01-012021-06-300001771910IFRS-Full：財務份額成員2021-01-012021-06-300001771910IFRS-Full：SharePremiumMembers2021-01-012021-06-300001771910IFRS-FULL：其他保留成員2021-01-012021-06-30ADC：子公司ISO 4217：美元ISO4217：英鎊00017719102021-01-012021-12-31Xbrli：純0001771910IFRS-Full：InterestRateRiskMemberADC：RiskFree InterestRateMember2022-01-012022-06-300001771910IFRS-Full：InterestRateRiskMemberADC：RiskFree InterestRateMemberAdc:FacilityAgreementWithDeerfieldPartnersLPTrancheOneMember2022-06-300001771910IFRS-Full：InterestRateRiskMemberADC：ImpliedBondYeldMembers2022-01-012022-06-300001771910IFRS-Full：InterestRateRiskMemberADC：ImpliedBondYeldMembersAdc:FacilityAgreementWithDeerfieldPartnersLPTrancheOneMember2022-06-300001771910ADC：VolatilityRiskMembers2022-01-012022-06-300001771910ADC：VolatilityRiskMembersAdc:FacilityAgreementWithDeerfieldPartnersLPTrancheOneMember2022-06-300001771910IFRS-Full：InterestRateRiskMemberADC：RiskFree InterestRateMemberAdc:FacilityAgreementWithDeerfieldPartnersLPTrancheTwoMember2022-06-300001771910IFRS-Full：InterestRateRiskMemberADC：ImpliedBondYeldMembersAdc:FacilityAgreementWithDeerfieldPartnersLPTrancheTwoMember2022-06-300001771910ADC：VolatilityRiskMembersAdc:FacilityAgreementWithDeerfieldPartnersLPTrancheTwoMember2022-06-3000017719102022-01-182022-01-18ADC：細分市場0001771910ADC：外部成本成員2022-04-012022-06-300001771910ADC：外部成本成員2021-04-012021-06-300001771910ADC：外部成本成員2022-01-012022-06-300001771910ADC：外部成本成員2021-01-012021-06-300001771910ADC：員工擴展成員2022-04-012022-06-300001771910ADC：員工擴展成員2021-04-012021-06-300001771910ADC：員工擴展成員2022-01-012022-06-300001771910ADC：員工擴展成員2021-01-012021-06-300001771910ADC：抗體的製造成員2021-01-012021-06-300001771910Adc:FacilityAgreementWithDeerfieldPartnersLPTrancheOneMember2020-05-190001771910Adc:FacilityAgreementWithDeerfieldPartnersLPTrancheTwoMember2020-04-2400017719102021-04-012021-04-300001771910ADC：ZYNLONTAFRDM成員2022-04-012022-06-300001771910ADC：ZYNLONTAFRDM成員2022-01-012022-06-300001771910ADC：DosingOf指定人數成員ADC：MilestonePaymentMember2022-01-012022-06-300001771910Adc:SuccessfulCompletionOfInVivoEfficacyStudiesMemberADC：MilestonePaymentMember2022-01-012022-06-300001771910ADC：許可獲取和抗體ZYNLONTAME成員ADC：MilestonePaymentMember2021-01-012021-06-300001771910ADC：MilestonePaymentMemberAdc:LicenseToUseTechnologyToGenerateAntibodyDrugConjugatesZYNLONTAMember2021-01-012021-06-300001771910ADC：ZYNLONTAME成員2021-01-012021-06-300001771910Adc:LicenseToUseTechnologyToGenerateAntibodyDrugConjugatesZYNLONTA2MemberADC：許可證支付成員2021-01-012021-06-300001771910IFRS-Full：Gross CarryingAmount MemberADC：許可InfiniteLivedMember2021-12-310001771910ADC：內部開發成本成員IFRS-Full：Gross CarryingAmount Member2021-12-310001771910ADC：許可定義實時成員IFRS-Full：Gross CarryingAmount Member2021-12-310001771910IFRS-FULL：計算機軟件成員IFRS-Full：Gross CarryingAmount Member2021-12-310001771910IFRS-Full：Gross CarryingAmount Member2021-12-310001771910IFRS-Full：Gross CarryingAmount MemberADC：許可InfiniteLivedMember2022-01-012022-06-300001771910ADC：內部開發成本成員IFRS-Full：Gross CarryingAmount Member2022-01-012022-06-300001771910ADC：許可定義實時成員IFRS-Full：Gross CarryingAmount Member2022-01-012022-06-300001771910IFRS-FULL：計算機軟件成員IFRS-Full：Gross CarryingAmount Member2022-01-012022-06-300001771910IFRS-Full：Gross CarryingAmount Member2022-01-012022-06-300001771910IFRS-Full：Gross CarryingAmount MemberADC：許可InfiniteLivedMember2022-06-300001771910ADC：內部開發成本成員IFRS-Full：Gross CarryingAmount Member2022-06-300001771910ADC：許可定義實時成員IFRS-Full：Gross CarryingAmount Member2022-06-300001771910IFRS-FULL：計算機軟件成員IFRS-Full：Gross CarryingAmount Member2022-06-300001771910IFRS-Full：Gross CarryingAmount Member2022-06-300001771910Ifrs-full:AccumulatedDepreciationAndAmortisationMemberADC：許可InfiniteLivedMember2021-12-310001771910ADC：內部開發成本成員Ifrs-full:AccumulatedDepreciationAndAmortisationMember2021-12-310001771910ADC：許可定義實時成員Ifrs-full:AccumulatedDepreciationAndAmortisationMember2021-12-310001771910IFRS-FULL：計算機軟件成員Ifrs-full:AccumulatedDepreciationAndAmortisationMember2021-12-310001771910Ifrs-full:AccumulatedDepreciationAndAmortisationMember2021-12-310001771910Ifrs-full:AccumulatedDepreciationAndAmortisationMemberADC：許可InfiniteLivedMember2022-01-012022-06-300001771910ADC：內部開發成本成員Ifrs-full:AccumulatedDepreciationAndAmortisationMember2022-01-012022-06-300001771910ADC：許可定義實時成員Ifrs-full:AccumulatedDepreciationAndAmortisationMember2022-01-012022-06-300001771910IFRS-FULL：計算機軟件成員Ifrs-full:AccumulatedDepreciationAndAmortisationMember2022-01-012022-06-300001771910Ifrs-full:AccumulatedDepreciationAndAmortisationMember2022-01-012022-06-300001771910Ifrs-full:AccumulatedDepreciationAndAmortisationMemberADC：許可InfiniteLivedMember2022-06-300001771910ADC：內部開發成本成員Ifrs-full:AccumulatedDepreciationAndAmortisationMember2022-06-300001771910ADC：許可定義實時成員Ifrs-full:AccumulatedDepreciationAndAmortisationMember2022-06-300001771910IFRS-FULL：計算機軟件成員Ifrs-full:AccumulatedDepreciationAndAmortisationMember2022-06-300001771910Ifrs-full:AccumulatedDepreciationAndAmortisationMember2022-06-300001771910ADC：許可InfiniteLivedMember2022-06-300001771910ADC：內部開發成本成員2022-06-300001771910ADC：許可定義實時成員2022-06-300001771910IFRS-FULL：計算機軟件成員2022-06-300001771910IFRS-Full：Gross CarryingAmount MemberADC：許可InfiniteLivedMember2020-12-310001771910ADC：內部開發成本成員IFRS-Full：Gross CarryingAmount Member2020-12-310001771910ADC：許可定義實時成員IFRS-Full：Gross CarryingAmount Member2020-12-310001771910IFRS-FULL：計算機軟件成員IFRS-Full：Gross CarryingAmount Member2020-12-310001771910IFRS-Full：Gross CarryingAmount Member2020-12-310001771910IFRS-Full：Gross CarryingAmount MemberADC：許可InfiniteLivedMember2021-01-012021-06-300001771910ADC：內部開發成本成員IFRS-Full：Gross CarryingAmount Member2021-01-012021-06-300001771910ADC：許可定義實時成員IFRS-Full：Gross CarryingAmount Member2021-01-012021-06-300001771910IFRS-FULL：計算機軟件成員IFRS-Full：Gross CarryingAmount Member2021-01-012021-06-300001771910IFRS-Full：Gross CarryingAmount Member2021-01-012021-06-300001771910IFRS-Full：Gross CarryingAmount MemberADC：許可InfiniteLivedMember2021-06-300001771910ADC：內部開發成本成員IFRS-Full：Gross CarryingAmount Member2021-06-300001771910ADC：許可定義實時成員IFRS-Full：Gross CarryingAmount Member2021-06-300001771910IFRS-FULL：計算機軟件成員IFRS-Full：Gross CarryingAmount Member2021-06-300001771910IFRS-Full：Gross CarryingAmount Member2021-06-300001771910Ifrs-full:AccumulatedDepreciationAndAmortisationMemberADC：許可InfiniteLivedMember2020-12-310001771910ADC：內部開發成本成員Ifrs-full:AccumulatedDepreciationAndAmortisationMember2020-12-310001771910ADC：許可定義實時成員Ifrs-full:AccumulatedDepreciationAndAmortisationMember2020-12-310001771910IFRS-FULL：計算機軟件成員Ifrs-full:AccumulatedDepreciationAndAmortisationMember2020-12-310001771910Ifrs-full:AccumulatedDepreciationAndAmortisationMember2020-12-310001771910Ifrs-full:AccumulatedDepreciationAndAmortisationMemberADC：許可InfiniteLivedMember2021-01-012021-06-300001771910ADC：內部開發成本成員Ifrs-full:AccumulatedDepreciationAndAmortisationMember2021-01-012021-06-300001771910ADC：許可定義實時成員Ifrs-full:AccumulatedDepreciationAndAmortisationMember2021-01-012021-06-300001771910IFRS-FULL：計算機軟件成員Ifrs-full:AccumulatedDepreciationAndAmortisationMember2021-01-012021-06-300001771910Ifrs-full:AccumulatedDepreciationAndAmortisationMember2021-01-012021-06-300001771910Ifrs-full:AccumulatedDepreciationAndAmortisationMemberADC：許可InfiniteLivedMember2021-06-300001771910ADC：內部開發成本成員Ifrs-full:AccumulatedDepreciationAndAmortisationMember2021-06-300001771910ADC：許可定義實時成員Ifrs-full:AccumulatedDepreciationAndAmortisationMember2021-06-300001771910IFRS-FULL：計算機軟件成員Ifrs-full:AccumulatedDepreciationAndAmortisationMember2021-06-300001771910Ifrs-full:AccumulatedDepreciationAndAmortisationMember2021-06-300001771910ADC：許可InfiniteLivedMember2021-06-300001771910ADC：內部開發成本成員2021-06-300001771910ADC：許可定義實時成員2021-06-300001771910IFRS-FULL：計算機軟件成員2021-06-300001771910ADC：Overland ADCT BioPharmaCyLimited成員2020-12-142020-12-14ADC：產品0001771910ADC：Overland ADCT BioPharmaCyLimited成員2021-12-310001771910ADC：Overland ADCT BioPharmaCyLimited成員2022-01-012022-06-300001771910ADC：Overland ADCT BioPharmaCyLimited成員2022-06-300001771910ADC：Overland ADCT BioPharmaCyLimited成員2020-12-310001771910ADC：Overland ADCT BioPharmaCyLimited成員2021-01-012021-06-300001771910ADC：Overland ADCT BioPharmaCyLimited成員2021-06-300001771910ADC：Overland ADCT BioPharmaCyLimited成員2022-04-012022-06-300001771910ADC：Overland ADCT BioPharmaCyLimited成員2021-04-012021-06-300001771910國際財務報告準則-完整：建築業成員IFRS-Full：Gross CarryingAmount Member2021-12-310001771910IFRS-Full：Gross CarryingAmount MemberIFRS-Full：車輛成員2021-12-310001771910國際財務報告準則-完整：建築業成員IFRS-Full：Gross CarryingAmount Member2022-01-012022-06-300001771910IFRS-Full：Gross CarryingAmount MemberIFRS-Full：車輛成員2022-01-012022-06-300001771910國際財務報告準則-完整：建築業成員IFRS-Full：Gross CarryingAmount Member2022-06-300001771910IFRS-Full：Gross CarryingAmount MemberIFRS-Full：車輛成員2022-06-300001771910國際財務報告準則-完整：建築業成員Ifrs-full:AccumulatedDepreciationAndAmortisationMember2021-12-310001771910Ifrs-full:AccumulatedDepreciationAndAmortisationMemberIFRS-Full：車輛成員2021-12-310001771910國際財務報告準則-完整：建築業成員Ifrs-full:AccumulatedDepreciationAndAmortisationMember2022-01-012022-06-300001771910Ifrs-full:AccumulatedDepreciationAndAmortisationMemberIFRS-Full：車輛成員2022-01-012022-06-300001771910國際財務報告準則-完整：建築業成員Ifrs-full:AccumulatedDepreciationAndAmortisationMember2022-06-300001771910Ifrs-full:AccumulatedDepreciationAndAmortisationMemberIFRS-Full：車輛成員2022-06-300001771910國際財務報告準則-完整：建築業成員2022-06-300001771910IFRS-Full：車輛成員2022-06-300001771910國際財務報告準則-完整：建築業成員IFRS-Full：Gross CarryingAmount Member2020-12-310001771910IFRS-Full：Gross CarryingAmount MemberIFRS-Full：車輛成員2020-12-310001771910國際財務報告準則-完整：建築業成員IFRS-Full：Gross CarryingAmount Member2021-01-012021-06-300001771910IFRS-Full：Gross CarryingAmount MemberIFRS-Full：車輛成員2021-01-012021-06-300001771910國際財務報告準則-完整：建築業成員IFRS-Full：Gross CarryingAmount Member2021-06-300001771910IFRS-Full：Gross CarryingAmount MemberIFRS-Full：車輛成員2021-06-300001771910國際財務報告準則-完整：建築業成員Ifrs-full:AccumulatedDepreciationAndAmortisationMember2020-12-310001771910Ifrs-full:AccumulatedDepreciationAndAmortisationMemberIFRS-Full：車輛成員2020-12-310001771910國際財務報告準則-完整：建築業成員Ifrs-full:AccumulatedDepreciationAndAmortisationMember2021-01-012021-06-300001771910Ifrs-full:AccumulatedDepreciationAndAmortisationMemberIFRS-Full：車輛成員2021-01-012021-06-300001771910國際財務報告準則-完整：建築業成員Ifrs-full:AccumulatedDepreciationAndAmortisationMember2021-06-300001771910Ifrs-full:AccumulatedDepreciationAndAmortisationMemberIFRS-Full：車輛成員2021-06-300001771910國際財務報告準則-完整：建築業成員2021-06-300001771910IFRS-Full：車輛成員2021-06-30Utr：Sqm0001771910ADC：研究和開發費用成員2022-04-012022-06-300001771910ADC：研究和開發費用成員2021-04-012021-06-300001771910ADC：研究和開發費用成員2022-01-012022-06-300001771910ADC：研究和開發費用成員2021-01-012021-06-300001771910ADC：一般和行政費用成員2022-04-012022-06-300001771910ADC：一般和行政費用成員2021-04-012021-06-300001771910ADC：一般和行政費用成員2022-01-012022-06-300001771910ADC：一般和行政費用成員2021-01-012021-06-300001771910國際財務報告準則-完整：建築業成員2021-12-310001771910IFRS-Full：車輛成員2021-12-310001771910國際財務報告準則-完整：建築業成員2022-01-012022-06-300001771910IFRS-Full：車輛成員2022-01-012022-06-300001771910國際財務報告準則-完整：建築業成員2022-06-300001771910IFRS-Full：車輛成員2022-06-300001771910國際財務報告準則-完整：建築業成員2020-12-310001771910IFRS-Full：車輛成員2020-12-310001771910國際財務報告準則-完整：建築業成員2022-01-012022-03-310001771910IFRS-Full：車輛成員2022-01-012022-03-3100017719102022-01-012022-03-310001771910國際財務報告準則-完整：建築業成員2021-01-012021-06-300001771910IFRS-Full：車輛成員2021-01-012021-06-300001771910國際財務報告準則-完整：建築業成員2021-06-300001771910IFRS-Full：車輛成員2021-06-300001771910Adc:FacilityAgreementWithDeerfieldPartnersLPMember2020-04-240001771910Adc:FacilityAgreementWithDeerfieldPartnersLPMember2020-04-242020-04-24ADC：借款組件0001771910Adc:FacilityAgreementWithDeerfieldPartnersLPTrancheOneMember2020-04-240001771910Adc:FacilityAgreementWithDeerfieldPartnersLPTrancheOneMember2022-04-012022-06-300001771910Adc:FacilityAgreementWithDeerfieldPartnersLPTrancheOneMember2022-01-012022-06-300001771910Adc:FacilityAgreementWithDeerfieldPartnersLPTrancheOneMember2021-04-012021-06-300001771910Adc:FacilityAgreementWithDeerfieldPartnersLPTrancheOneMember2021-01-012021-06-300001771910Adc:FacilityAgreementWithDeerfieldPartnersLPTrancheOneMember2022-06-300001771910Adc:FacilityAgreementWithDeerfieldPartnersLPTrancheOneMember2021-12-310001771910ADC：InitialPublicOfferingMember2020-05-192020-05-190001771910IFRS-Full：編寫PutOptionsMembersAdc:FacilityAgreementWithDeerfieldPartnersLPTrancheOneMemberIFRS-Full：衍生品成員2022-06-300001771910IFRS-Full：編寫PutOptionsMembersAdc:FacilityAgreementWithDeerfieldPartnersLPTrancheOneMemberIFRS-Full：衍生品成員2021-12-310001771910ADC：ForcedConversionPriceMemberAdc:FacilityAgreementWithDeerfieldPartnersLPTrancheOneMemberIFRS-Full：衍生品成員2022-06-300001771910ADC：ForcedConversionPriceMemberAdc:FacilityAgreementWithDeerfieldPartnersLPTrancheOneMemberIFRS-Full：衍生品成員2021-12-310001771910ADC：SharePriceMemberAdc:FacilityAgreementWithDeerfieldPartnersLPTrancheOneMemberIFRS-Full：衍生品成員2022-06-300001771910ADC：SharePriceMemberAdc:FacilityAgreementWithDeerfieldPartnersLPTrancheOneMemberIFRS-Full：衍生品成員2021-12-310001771910Adc:FacilityAgreementWithDeerfieldPartnersLPTrancheOneMemberADC：RiskFree InterestRateMemberIFRS-Full：衍生品成員2022-06-300001771910Adc:FacilityAgreementWithDeerfieldPartnersLPTrancheOneMemberADC：RiskFree InterestRateMemberIFRS-Full：衍生品成員2021-12-310001771910ADC：預期數量成員Adc:FacilityAgreementWithDeerfieldPartnersLPTrancheOneMemberIFRS-Full：衍生品成員2022-06-300001771910ADC：預期數量成員Adc:FacilityAgreementWithDeerfieldPartnersLPTrancheOneMemberIFRS-Full：衍生品成員2021-12-310001771910ADC：預期術語成員Adc:FacilityAgreementWithDeerfieldPartnersLPTrancheOneMemberIFRS-Full：衍生品成員2022-06-30ADC：句號0001771910ADC：預期術語成員Adc:FacilityAgreementWithDeerfieldPartnersLPTrancheOneMemberIFRS-Full：衍生品成員2021-12-310001771910Adc:FacilityAgreementWithDeerfieldPartnersLPTrancheOneMemberADC：DiviendYeldMembersIFRS-Full：衍生品成員2022-06-300001771910Adc:FacilityAgreementWithDeerfieldPartnersLPTrancheOneMemberADC：DiviendYeldMembersIFRS-Full：衍生品成員2021-12-310001771910ADC：恢復率成員Adc:FacilityAgreementWithDeerfieldPartnersLPTrancheOneMemberIFRS-Full：衍生品成員2022-06-300001771910ADC：恢復率成員Adc:FacilityAgreementWithDeerfieldPartnersLPTrancheOneMemberIFRS-Full：衍生品成員2021-12-310001771910ADC：ImpliedBondYeldMembersAdc:FacilityAgreementWithDeerfieldPartnersLPTrancheOneMemberIFRS-Full：衍生品成員2022-06-300001771910ADC：ImpliedBondYeldMembersAdc:FacilityAgreementWithDeerfieldPartnersLPTrancheOneMemberIFRS-Full：衍生品成員2021-12-310001771910Adc:FacilityAgreementWithDeerfieldPartnersLPMember2022-06-300001771910Adc:FacilityAgreementWithDeerfieldPartnersLPTrancheTwoMember2021-04-012021-06-300001771910Adc:FacilityAgreementWithDeerfieldPartnersLPTrancheTwoMember2021-01-012021-06-300001771910Adc:FacilityAgreementWithDeerfieldPartnersLPTrancheTwoMemberIFRS-Full：TopOfRangeMember2020-04-242020-04-240001771910IFRS-Full：編寫PutOptionsMembersAdc:FacilityAgreementWithDeerfieldPartnersLPTrancheTwoMemberIFRS-Full：衍生品成員2021-04-230001771910ADC：ForcedConversionPriceMemberAdc:FacilityAgreementWithDeerfieldPartnersLPTrancheTwoMemberIFRS-Full：衍生品成員2021-04-230001771910ADC：SharePriceMemberAdc:FacilityAgreementWithDeerfieldPartnersLPTrancheTwoMemberIFRS-Full：衍生品成員2021-04-230001771910Adc:FacilityAgreementWithDeerfieldPartnersLPTrancheTwoMemberADC：RiskFree InterestRateMemberIFRS-Full：衍生品成員2021-04-230001771910ADC：預期數量成員Adc:FacilityAgreementWithDeerfieldPartnersLPTrancheTwoMemberIFRS-Full：衍生品成員2021-04-230001771910ADC：預期術語成員Adc:FacilityAgreementWithDeerfieldPartnersLPTrancheTwoMemberIFRS-Full：衍生品成員2021-04-230001771910Adc:FacilityAgreementWithDeerfieldPartnersLPTrancheTwoMemberADC：DiviendYeldMembersIFRS-Full：衍生品成員2021-04-230001771910ADC：恢復率成員Adc:FacilityAgreementWithDeerfieldPartnersLPTrancheTwoMemberIFRS-Full：衍生品成員2021-04-230001771910ADC：ImpliedBondYeldMembersAdc:FacilityAgreementWithDeerfieldPartnersLPTrancheTwoMemberIFRS-Full：衍生品成員2021-04-230001771910Adc:FacilityAgreementWithDeerfieldPartnersLPTrancheTwoMember2020-04-242020-04-240001771910IFRS-Full：編寫PutOptionsMembersAdc:FacilityAgreementWithDeerfieldPartnersLPTrancheTwoMember2022-06-300001771910IFRS-Full：編寫PutOptionsMembersAdc:FacilityAgreementWithDeerfieldPartnersLPTrancheTwoMember2021-04-230001771910Adc:FacilityAgreementWithDeerfieldPartnersLPTrancheTwoMemberADC：ForcedConversionPriceMember2022-06-300001771910Adc:FacilityAgreementWithDeerfieldPartnersLPTrancheTwoMemberADC：ForcedConversionPriceMember2021-04-230001771910ADC：SharePriceMemberAdc:FacilityAgreementWithDeerfieldPartnersLPTrancheTwoMember2022-06-300001771910ADC：SharePriceMemberAdc:FacilityAgreementWithDeerfieldPartnersLPTrancheTwoMember2021-04-230001771910Adc:FacilityAgreementWithDeerfieldPartnersLPTrancheTwoMemberADC：RiskFree InterestRateMember2022-06-300001771910Adc:FacilityAgreementWithDeerfieldPartnersLPTrancheTwoMemberADC：RiskFree InterestRateMember2021-04-230001771910ADC：預期數量成員Adc:FacilityAgreementWithDeerfieldPartnersLPTrancheTwoMember2022-06-300001771910ADC：預期數量成員Adc:FacilityAgreementWithDeerfieldPartnersLPTrancheTwoMember2021-04-230001771910ADC：預期術語成員Adc:FacilityAgreementWithDeerfieldPartnersLPTrancheTwoMember2022-06-300001771910ADC：預期術語成員Adc:FacilityAgreementWithDeerfieldPartnersLPTrancheTwoMember2021-04-230001771910Adc:FacilityAgreementWithDeerfieldPartnersLPTrancheTwoMemberADC：DiviendYeldMembers2022-06-300001771910Adc:FacilityAgreementWithDeerfieldPartnersLPTrancheTwoMemberADC：DiviendYeldMembers2021-04-230001771910ADC：恢復率成員Adc:FacilityAgreementWithDeerfieldPartnersLPTrancheTwoMember2022-06-300001771910ADC：恢復率成員Adc:FacilityAgreementWithDeerfieldPartnersLPTrancheTwoMember2021-04-230001771910ADC：ImpliedBondYeldMembersAdc:FacilityAgreementWithDeerfieldPartnersLPTrancheTwoMember2022-06-300001771910ADC：ImpliedBondYeldMembersAdc:FacilityAgreementWithDeerfieldPartnersLPTrancheTwoMember2021-04-230001771910Adc:FacilityAgreementWithDeerfieldPartnersLPTrancheTwoMember2022-04-012022-06-300001771910Adc:FacilityAgreementWithDeerfieldPartnersLPTrancheTwoMember2022-01-012022-06-300001771910Adc:FacilityAgreementWithDeerfieldPartnersLPTrancheTwoMember2022-06-300001771910Adc:FacilityAgreementWithDeerfieldPartnersLPTrancheTwoMember2021-12-310001771910Adc:FacilityAgreementWithDeerfieldPartnersLPMemberADC：ResidualLoanMember2022-06-300001771910Adc:FacilityAgreementWithDeerfieldPartnersLPTrancheOneMemberADC：ResidualLoanMember2022-04-012022-06-300001771910Adc:FacilityAgreementWithDeerfieldPartnersLPTrancheOneMemberADC：ResidualLoanMember2022-01-012022-06-300001771910Adc:FacilityAgreementWithDeerfieldPartnersLPMemberADC：ResidualLoanMember2022-01-012022-06-300001771910Adc:FacilityAgreementWithDeerfieldPartnersLPTrancheOneMemberADC：ResidualLoanMember2022-06-300001771910Adc:FacilityAgreementWithDeerfieldPartnersLPMemberADC：ResidualLoanMember2021-12-310001771910Adc:FacilityAgreementWithDeerfieldPartnersLPTrancheOneMemberADC：ResidualLoanMember2021-12-310001771910Adc:FacilityAgreementWithDeerfieldPartnersLPTrancheTwoMemberIFRS-Full：衍生品成員2021-01-012021-06-3000017719102021-06-04Xbrli：共享0001771910ADC：A2019股權激勵計劃成員2019-11-300001771910ADC：A2019股權激勵計劃成員2022-06-300001771910ADC：EmployeeStockOptionMember2021-03-222021-03-220001771910ADC：受限共享單位RSU成員2021-03-222021-03-220001771910ADC：EmployeeStockOptionMember2022-05-112022-05-110001771910ADC：A2019股權激勵計劃成員2022-01-012022-06-300001771910ADC：EmployeeStockOptionMember2022-04-012022-06-300001771910ADC：EmployeeStockOptionMember2022-01-012022-06-300001771910ADC：EmployeeStockOptionMember2021-04-012021-06-300001771910ADC：EmployeeStockOptionMember2021-01-012021-06-300001771910ADC：TrancheThreeMemberADC：EmployeeStockOptionMember2022-01-012022-06-300001771910ADC：TranscheTwoMembersADC：EmployeeStockOptionMember2022-01-012022-06-300001771910ADC：EmployeeStockOptionMemberADC：TranscheFourMembers2022-01-012022-06-300001771910ADC：TrancheOneMembersADC：EmployeeStockOptionMember2022-01-012022-06-300001771910ADC：EmployeeStockOptionMember2022-06-300001771910SRT：最小成員數2022-04-012022-06-300001771910SRT：最大成員數2022-04-012022-06-300001771910SRT：最小成員數2021-01-012021-06-300001771910SRT：最大成員數2021-01-012021-06-300001771910ADC：受限共享單位RSU成員2022-01-012022-06-300001771910ADC：Special RetentionAwardMemberADC：受限共享單位RSU成員2022-01-012022-06-300001771910ADC：Special RetentionAwardMemberADC：TrancheOneMembers2022-01-012022-06-300001771910ADC：TranscheTwoMembersADC：Special RetentionAwardMember2022-01-012022-06-300001771910ADC：受限共享單位RSU成員2022-04-012022-06-300001771910ADC：受限共享單位RSU成員2021-04-012021-06-300001771910ADC：受限共享單位RSU成員2021-01-012021-06-300001771910ADC：受限共享單位RSU成員2021-12-310001771910ADC：受限共享單位RSU成員2022-06-300001771910ADC：受限共享單位RSU成員ADC：年度股權獎成員2022-01-012022-06-300001771910ADC：EmployeeStockOptionMemberADC：A2019股權激勵計劃成員2022-04-012022-06-300001771910ADC：EmployeeStockOptionMemberADC：A2019股權激勵計劃成員2021-04-012021-06-300001771910ADC：EmployeeStockOptionMemberADC：A2019股權激勵計劃成員2022-01-012022-06-300001771910ADC：EmployeeStockOptionMemberADC：A2019股權激勵計劃成員2021-01-012021-06-300001771910ADC：受限的股票單位成員ADC：A2019股權激勵計劃成員2022-04-012022-06-300001771910ADC：受限的股票單位成員ADC：A2019股權激勵計劃成員2021-04-012021-06-300001771910ADC：受限的股票單位成員ADC：A2019股權激勵計劃成員2022-01-012022-06-300001771910ADC：受限的股票單位成員ADC：A2019股權激勵計劃成員2021-01-012021-06-300001771910ADC：獎勵計劃2014年成員2022-04-012022-06-300001771910ADC：獎勵計劃2014年成員2021-04-012021-06-300001771910ADC：獎勵計劃2014年成員2021-01-012021-06-3000017719102021-08-250001771910ADC：AuvenTreateuticsHoldingsLPM成員2022-01-012022-06-300001771910ADC：AuvenTreateuticsHoldingsLPM成員2022-04-012022-06-300001771910ADC：AuvenTreateuticsHoldingsLPM成員2021-04-012021-06-300001771910ADC：AuvenTreateuticsHoldingsLPM成員2021-01-012021-06-300001771910ADC：Overland ADCT BioPharmaCyLimited成員2022-04-012022-06-300001771910ADC：Overland ADCT BioPharmaCyLimited成員2022-01-012022-06-300001771910ADC：Overland ADCT BioPharmaCyLimited成員2021-04-012021-06-300001771910ADC：Overland ADCT BioPharmaCyLimited成員2021-01-012021-06-300001771910ADC：Overland ADCT BioPharmaCyLimited成員2022-06-300001771910ADC：Overland ADCT BioPharmaCyLimited成員2021-12-310001771910Adc:A2019EquityIncentivePlanShareOptionsMember2022-04-012022-06-300001771910Adc:A2019EquityIncentivePlanShareOptionsMember2021-04-012021-06-300001771910Adc:A2019EquityIncentivePlanShareOptionsMember2022-01-012022-06-300001771910Adc:A2019EquityIncentivePlanShareOptionsMember2021-01-012021-06-300001771910ADC：A2019股權激勵計劃RSUsMembers2022-04-012022-06-300001771910ADC：A2019股權激勵計劃RSUsMembers2021-04-012021-06-300001771910ADC：A2019股權激勵計劃RSUsMembers2022-01-012022-06-300001771910ADC：A2019股權激勵計劃RSUsMembers2021-01-012021-06-300001771910Adc:ConvertibleLoansContingentlyIssuableSharesMember2022-04-012022-06-300001771910Adc:ConvertibleLoansContingentlyIssuableSharesMember2021-04-012021-06-300001771910Adc:ConvertibleLoansContingentlyIssuableSharesMember2022-01-012022-06-300001771910Adc:ConvertibleLoansContingentlyIssuableSharesMember2021-01-012021-06-300001771910ADC：獎勵計劃2014年成員2022-01-012022-06-300001771910ADC：獎勵計劃2014年成員2021-01-012021-06-300001771910ADC：許可協議成員2022-07-012022-07-310001771910ADC：應用程序批准成員2022-01-012022-01-31 美國
美國證券交易委員會
華盛頓特區，20549
表格6-K
外國私人發行人根據1934年《證券交易法》第13a-16條或15d-16條提交的報告
2022年8月
委託文件編號：001-39071
ADC治療公司
(註冊人的確切姓名載於其章程)
比奧波爾
科尼奇3B路
1066埃帕林吉斯
瑞士
(主要行政辦公室地址)
用複選標記表示註冊人是否在表格20-F或表格40-F的封面下提交或將提交年度報告：
用複選標記表示註冊人是否按照S-T規則101(B)(1)所允許的紙質形式提交了表格6-K：☐
用複選標記表示註冊人是否按照S-T規則101(B)(7)所允許的紙質形式提交表格6-K：☐
以引用方式成立為法團
這份表格6-K的報告(本報告附件99.3除外)，包括本報告的附件99.1和99.2，應被視為通過引用併入ADC Treateutics SA的表格F-3(註冊號333-256686和第333-256807)的註冊聲明，並自本報告提交之日起成為其中的一部分，但不得被隨後提交或提交的文件或報告所取代。
簽名
根據1934年《證券交易法》的要求，註冊人已正式促使本報告由正式授權的簽署人代表其簽署。
| | | | | | | | |
| ADC治療公司 |
| | |
| | |
| 發信人： | /s/詹妮弗·克里爾 |
| 姓名： | 詹妮弗·克里爾 |
| 標題： | 首席財務官 |
| | |
| 日期：2022年8月9日 | | |
展品索引
| | | | | |
| 展品編號 | 描述 |
| 99.1 | 截至2022年6月30日以及截至2022年6月30日的三個月和六個月的未經審計的IFRS綜合中期財務報表 |
| 99.2 | 管理層對財務狀況和經營成果的探討與分析 |
| 99.3 | 新聞稿日期：2022年8月9日 |
| |
| 101.SCH | XBRL分類擴展架構文檔 |
| 101.CAL | XBRL分類擴展計算鏈接庫文檔 |
| 101.DEF | XBRL分類擴展定義Linkbase文檔 |
| 101.LAB | XBRL分類擴展標籤Linkbase文檔 |
| 101.PRE | XBRL分類擴展演示文稿Linkbase文檔 |
| 104 | 封面交互數據文件(格式為內聯XBRL，包含在附件101中)
|